HARTFORD, CT – Today, State Senator Will Haskell (D-Westport) commended colleagues State Senator Matt Lesser (D-Middletown) and State Representative Sean Scanlon (D-Guilford), the co-chairs of the legislature’s Insurance and Real Estate Committee, as they led passage in committee of a proposed bill to cap the cost of insulin prescriptions at $50, the lowest cap in the country. The insulin legislation, Senate Bill (SB) 1, is co-sponsored by Sen. Haskell and passed in a bipartisan 17-1 tally. It will address the dire problem that one in four type 1 diabetes patients ration their insulin. The bill will now move to the state Senate for a vote.
The bill, SB 1, contains several provisions to help diabetes patients and their families afford insulin.
They include:
Capping insulin costs including for all insulin and diabetes supplies at $150/month. This would be the toughest cap in the country.
- Insulin is $50 per 30 day.
- Non-insulin drugs (glucose) is $50 per 30 day.
- Devices/equipment is $100 per 30 day.
- Insulin + devices is $100 per month.
Allowing patients to go to a pharmacist up to three times a year on an emergency basis to get insulin filled without a prescription. Insurance must cover the cost up to 3 times a year for their policyholders. Everyone would have access to emergency insulin if they go to a pharmacist.
Bill language was released in February following an announcement of the bill by state Senate Democratic Caucus in January. This proposal is priority number one for Senate Democrats for the 2020 legislative session. It is also priority No. 1 for the thousands of Connecticut residents suffering from diabetes, struggling to afford life-saving insulin due to outrageously high prices.
“We cannot allow thousands of people to continue to choose between life-saving medication like insulin and paying their bills,” said Sen. Haskell. “This is a disparity we must stop, and I am thankful Sen. Lesser and Rep. Scanlon are fighting to do just that. I will proudly vote for this legislation when it reaches the Senate floor.”
“Today, Connecticut is one step closer to having the strongest insulin cap in the country,” said Sen. Lesser. “Insulin isn’t optional, this bill will save lives. I’m grateful to the support from our Committee members and look forward to carrying Senate Bill 1 forward in the Senate.”
“Today’s vote gets us one step closer to making sure that no one in Connecticut ever has to worry about being able to afford the insulin they need to survive again,” said Rep. Scanlon. “Whether it’s a senior rationing their insulin because they can’t afford it or the young man who said he pays more for insulin each year than on his tuition to one of our state universities, it’s clear from what we’ve heard that we need to act and I’m glad we are.”
This timely proposed legislation comes as excessive insulin costs are severely impacting Connecticut’s diabetes patients. According to Health Care Cost Institute, the cost of insulin nearly tripled between 2002 and 2013, then doubled from that from 2012 to 2016. According to the AARP, “Americans with diabetes, the majority of whom are older adults, face insulin prices that average more than $5,000 per year.” Diabetes is the seventh-leading cause of death in Connecticut. This proposed legislation will save lives in Connecticut, ensuring the 11.4 percent of state’s population with diabetes, and 36.5 percent with prediabetes, can afford Insulin without having to adopt the unsafe practice of rationing their medicine.
Across the country, state governments are grappling with bringing down insulin costs. According to the AARP, last year Colorado passed legislation to cap out-of-pocket cost for insulin at $100 for a 30-day supply. According to a CNN report, Virginia’s House of Delegates passed legislation preventing insurance companies from charging co-pays over $30 for a 30-day insulin supply, Tennessee lawmakers introduced a bill to ensure patients do not have to pay over $100 for a 30-day supply of the drug and Illinois passed a bill capping Insulin costs as well.